![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Nvision Gets FDA Clearance for Osteotomy Wedge System
Nvision Gets FDA Clearance for Osteotomy Wedge System
![ClearanceStamp_Blue.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Blue.gif?t=1576043968&width=430)
San Antonio, Tex.-based Nvision has been granted 510(k) marketing clearance by the FDA for its Trigon Osteotomy Wedge system, an implant that helps to promote bone fusion.
The device is composed of a radiolucent polymer that allows it to be used in X-rays, computed tomography (CT) scans and magnetic resonance imaging (MRI) for monitoring the healing process.
The wedge is made of a polyether ether ketone (PEEK) polymer developed by Invibio Biomaterial Solutions and it includes hydroxyapatite, a naturally occurring mineral that is the main inorganic component of bone. The implant encourages multidirectional bone healing and improved fixation.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct